Items where authors include "Levit, N.A."

Article

Cork, M.J., Thaçi, D., Eichenfield, L.F. et al. (8 more authors) (2023) Dupilumab safety and efficacy in a phase III open-label extension trial in children 6–11 years of age with severe atopic dermatitis. Dermatology and Therapy, 13. pp. 2697-2719. ISSN 2193-8210

Siegfried, E.C., Simpson, E.L. orcid.org/0000-0001-7353-5979, Cork, M.J. et al. (7 more authors) (2023) Dupilumab Treatment Leads to Rapid and Consistent Improvement of Atopic Dermatitis in All Anatomical Regions in Patients Aged 6 Months to 5 Years. Dermatology and Therapy, 13 (9). pp. 1987-2000. ISSN 2193-8210

Paller, A.S. orcid.org/0000-0001-6187-6549, Siegfried, E.C., Cork, M.J. orcid.org/0000-0003-4428-2428 et al. (8 more authors) (2023) Laboratory safety from a randomized 16-week phase III study of dupilumab in children aged 6 months to 5 years with moderate-to-severe atopic dermatitis. Pediatric Drugs, 25. pp. 67-77. ISSN 1174-5878

Paller, A.S., Wollenberg, A., Siegfried, E. et al. (12 more authors) (2021) Laboratory safety of dupilumab in patients aged 6–11 years with severe atopic dermatitis : results from a phase III clinical trial. Pediatric Drugs, 23 (5). pp. 515-527. ISSN 1174-5878